Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M D Houslay

Showing results (1-10 of 273) with videos related to

Pageof 28
Sort By:
Biochemical Pharmacology|December 1, 1980
Lipid substitution of mitochondrial monoamine oxidase can lead to the abolition of clorgyline selective inhibition without alteration in the A/B ratio assessed by substrate utilisationM D Houslay
Cellular Signalling|January 1, 1991
Gi-2 is at the centre of an active phosphorylation/dephosphorylation cycle in hepatocytes: the fine-tuning of stimulatory and inhibitory inputs into adenylate cyclase in normal and diabetic statesM D Houslay
Advances in Enzyme Regulation|January 1, 1995
Compartmentalization of cyclic AMP phosphodiesterases, signalling 'crosstalk', desensitization and the phosphorylation of Gi-2 add cell specific personalization to the control of the levels of the second messenger cyclic AMPM D Houslay
Clinical Endocrinology|June 1, 1992
G-protein linked receptors: a family probed by molecular cloning and mutagenesis proceduresM D Houslay
Bioscience Reports|January 1, 1981
Membrane phosphorylation: a crucial role in the action of insulin, EGF, and pp60src?M D Houslay
Biochemical Society Transactions|April 1, 1986
Insulin, glucagon and the receptor-mediated control of cyclic AMP concentrations in liver. Twenty-second Colworth medal lectureM D Houslay
Seminars in Cell & Developmental Biology|May 26, 1998
Adaptation in cyclic AMP signalling processes: a central role for cyclic AMP phosphodiesterasesM D Houslay
The Journal of Pharmacy and Pharmacology|November 1, 1977
A model for the selective mode of action of the irreversible monoamine oxidase inhibitors clorgyline and deprenyl, based on studies of their ability to activate a Ca2+--Mg2+ ATPase in defined lipid environmentsM D Houslay
Biochemical Society Transactions|November 1, 1996
The N-terminal alternately spliced regions of PDE4A cAMP-specific phosphodiesterases determine intracellular targeting and regulation of catalytic activityM D Houslay
Biochemical Society Transactions|October 1, 1979
Coupling of the glucagon receptor to adenylate cyclaseM D Houslay
Pageof 28

Showing results (1-10 of 273) with videos related to

Sort By:
Pageof 28
Biochemical Pharmacology|December 1, 1980
Lipid substitution of mitochondrial monoamine oxidase can lead to the abolition of clorgyline selective inhibition without alteration in the A/B ratio assessed by substrate utilisationM D Houslay
Cellular Signalling|January 1, 1991
Gi-2 is at the centre of an active phosphorylation/dephosphorylation cycle in hepatocytes: the fine-tuning of stimulatory and inhibitory inputs into adenylate cyclase in normal and diabetic statesM D Houslay
Advances in Enzyme Regulation|January 1, 1995
Compartmentalization of cyclic AMP phosphodiesterases, signalling 'crosstalk', desensitization and the phosphorylation of Gi-2 add cell specific personalization to the control of the levels of the second messenger cyclic AMPM D Houslay
Clinical Endocrinology|June 1, 1992
G-protein linked receptors: a family probed by molecular cloning and mutagenesis proceduresM D Houslay
Bioscience Reports|January 1, 1981
Membrane phosphorylation: a crucial role in the action of insulin, EGF, and pp60src?M D Houslay
Biochemical Society Transactions|April 1, 1986
Insulin, glucagon and the receptor-mediated control of cyclic AMP concentrations in liver. Twenty-second Colworth medal lectureM D Houslay
Seminars in Cell & Developmental Biology|May 26, 1998
Adaptation in cyclic AMP signalling processes: a central role for cyclic AMP phosphodiesterasesM D Houslay
The Journal of Pharmacy and Pharmacology|November 1, 1977
A model for the selective mode of action of the irreversible monoamine oxidase inhibitors clorgyline and deprenyl, based on studies of their ability to activate a Ca2+--Mg2+ ATPase in defined lipid environmentsM D Houslay
Biochemical Society Transactions|November 1, 1996
The N-terminal alternately spliced regions of PDE4A cAMP-specific phosphodiesterases determine intracellular targeting and regulation of catalytic activityM D Houslay
Biochemical Society Transactions|October 1, 1979
Coupling of the glucagon receptor to adenylate cyclaseM D Houslay
Pageof 28